Franklin Biotechnology Discovery Fund Advisor Class NMFQS:FTDZX

Health | Franklin Templeton Investments

$180.10

↓ $-2.10 (-1.15%)

Last Updated: Feb 15, 2026

Fund Information

Fund Category Health

Fund Family Franklin Templeton Investments

Fund Style Large

ISIN US3547133989

CUSIP 354713398

Inception Date -

Domicile -

Country USA

Fiscal Year End -

NAV Chart

Fund Metrics

Net Assets $1.42 Billion

Share Class Net Assets $-

Expense Ratio 0.77%

Expense Ratio Date -

Dividend Yield 0.02%

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Performance

YTD Return 2.43%

1-Year Return 52.88%

3-Year Return 22.72%

5-Year Return 6.10%

NAV $180.10

Previous Close Price $182.20

Last Update 2025-12-31

Dividend Information

Dividend Yield 0.02%

Dividend (ttm) 0.17

Dividend Growth -58.12%

Payout Frequency Annual

Ex-Dividend Date n/a

Ratings

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Beta (5Y) 1.23

About Franklin Biotechnology Discovery Fund Advisor Class

Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.

Detailed Metrics

Market Cap Distribution

AverageMarketCap 12027.19%

Giant 3.31%

Large 19.75%

Medium 21.25%

Micro 24.44%

Small 24.15%

Value & Growth Metrics

Book-Value Growth % -17.93%

Cash-Flow Growth % -4.78%

Dividend Yield % 0.41%

Historical Earnings % -5.10%

Long-Term Earnings % 3.63%

Asset Allocation

Type	Net %	Long %	Short %	Category Average	benchmark
Bond	0.00%	0.00%	0.00%	0.18%	0.00%
Cash	1.74%	1.75%	0.01%	1.44%	0.00%
Non US Stock	11.77%	11.77%	0.00%	8.38%	0.23%
Not Classified	0.25%	0.25%	0.00%	0.00%	0.00%
Other	0.00%	0.00%	0.00%	0.14%	0.00%
US Stock	86.24%	86.24%	0.00%	90.06%	99.77%

Top Holdings

Name	Weight	Owned	Change
Amgen, Inc.	4.49%	-	-
Regeneron Pharmaceuticals, Inc.	4.09%	-	-
Vertex Pharmaceuticals, Inc.	4.56%	-	-
Insmed, Inc.	3.75%	-	-
Ascendis Pharma A/S	3.85%	-	-
Gilead Sciences, Inc.	5.57%	-	-
Intra-Cellular Therapies, Inc.	2.97%	-	-
Institutional Fiduciary Trust Money Market Portfolio	2.97%	-	-
Biogen, Inc.	2.93%	-	-
AstraZeneca plc	3.06%	-	-
Institutional Fiduciary Trust - Money Market Portfolio	3.85%	-	-
Argenx SE	4.14%	-	-
Jazz Pharmaceuticals plc	4.02%	-	-
Neurocrine Biosciences, Inc.	3.15%	-	-
Merus NV	3.87%	-	-
Alnylam Pharmaceuticals, Inc.	3.83%	-	-
Franklin Institutional U.S. Government Money Market Fund	3.47%	-	-

See the full breakdown of FTDZX fund's asset allocation and top holdings .

Sector Weights

Category	Subcategory	Amount %	Category Avg	Stocks %	Benchmark
Bond Sector	Cash and Equivalents	0.00%	88.82%	87.44%	0.00%
Bond Sector	Corporate	0.00%	11.18%	12.56%	0.00%
Bond Sector	Derivative	0.00%	0.00%	0.00%	0.00%
Bond Sector	Government	0.00%	0.00%	0.00%	0.00%
Bond Sector	Municipal	0.00%	0.00%	0.00%	0.00%
Bond Sector	Securitized	0.00%	0.00%	0.00%	0.00%
Cyclical	Basic Materials	0.00%	0.00%	0.00%	0.00%
Cyclical	Consumer Cyclical	0.00%	0.00%	0.00%	0.00%
Cyclical	Financial Services	0.00%	0.02%	0.00%	0.00%
Cyclical	Real Estate	0.00%	0.14%	0.00%	0.00%
Defensive	Consumer Defensive	0.00%	0.00%	0.00%	0.00%
Defensive	Healthcare	100.00%	99.80%	0.00%	100.00%
Defensive	Utilities	0.00%	0.00%	0.00%	0.00%
Sensitive	Communication Services	0.00%	0.00%	0.00%	0.00%
Sensitive	Energy	0.00%	0.02%	0.00%	0.00%
Sensitive	Industrials	0.00%	0.01%	0.00%	0.00%
Sensitive	Technology	0.00%	0.00%	0.00%	0.00%

World Regions

Region	Subregion	Category Average	Stocks Percent	Benchmark
Americas	Latin America	-	-	-
Americas	North America	91.79%	88.92%	99.77%
Greater Asia	Asia Developed	0.09%	-	-
Greater Asia	Asia Emerging	0.10%	-	-
Greater Asia	Australasia	0.07%	-	-
Greater Asia	Japan	0.40%	-	-
Greater Europe	Africa/Middle East	0.26%	-	-
Greater Europe	Europe Developed	5.28%	7.65%	0.10%
Greater Europe	Europe Emerging	-	-	-
Greater Europe	United Kingdom	2.01%	3.43%	0.13%

Dividend History

Date	Amount	Unadjusted Amount	Currency	Declaration Date	Record Date	Payment Date	Period
2022-12-20	$0.416	$0.416	USD	2022-12-20	2022-12-19	2022-12-20	Annual
2021-12-15	$1.412	$1.412	USD	2021-12-15	2021-12-14	2021-12-15	Annual
2016-12-15	$2.081	$2.081	USD	2016-12-15	2016-12-14	2016-12-19	Other
2012-12-17	$0.069	$0.069	USD	2012-12-17	2012-12-14	2012-12-19	Annual